Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7483 p705
22/29 December 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Separating professional regulation and representation General Pharmaceutical Council and a professional body for the Society


PDA says supportive professional body needed

Pharmacists need a supportive professional body, the Pharmacists’ Defence Association has told the Clarke Inquiry.

Giving evidence on what the future professional body should be like, Mark Koziol, PDA chairman, said that it should be a body that provides the tools that pharmacists need to do their jobs. These included setting educational standards, producing useful publications, practice guidance, helping pharmacists keep up to date, facilitating peer and specialist groups, supporting weaker or disadvantaged members of the profession and providing a powerful and unified voice.

It should be the professional body, and not the General Pharmaceutical Council, that sets or negotiates professional standards, he said. The GPhC could then police them.

The members of the professional body should be primarily pharmacy graduates, Mr Koziol went on, not GPhC registrants. And its purpose should be to further the intersts of these members. Pharmaceutical scientists, pharmacy technicians and qualified persons could be associate members.

The new professional body should have a fresh vision, a fresh approach and be focused on its members, with the new regulator being physically located as far away as possible. He attributed the Royal Pharmaceutical Society’s poor reputation among its members to the vigour with which it regulated them.

However, he said that the Society’s Royal Charter contains the provisions that the new professional body would need. But he added that the Society should undergo a root and branch shake-up and slim down its executive, if it were to avoid putting people off joining when it was no longer a requirement.

Mr Koziol suggested that the basic membership fee should be no more than £50 a year, with other income being generated from publishing activities and from selling extra services to members.

Back to Top


©The Pharmaceutical Journal